Neuroinflammation is a key pathological feature of Alzheimer’s disease, and pro-inflammatory cytokines are known to promote hyperphosphorylation of tau, partly through upregulation of tau-kinases such as GSK-3β [41,42,43]. The gene discussed is GSK3B; the disease is early-onset autosomal dominant Alzheimer disease.